SMTL ID : 1ec2.1

HIV-1 protease in complex with the inhibitor BEA428

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

1 x BEJ: N,N-[2,5-O-[DI-4-PYRIDIN-3-YL-BENZYL]-GLUCARYL]-DI-[VALYL-AMIDO-METHANE](Non-covalent)

BEJ.1: 26 residues within 4Å: Chain A: R.8, L.23, D.25, G.27, A.28, D.29, G.48, G.49, I.50, F.53, P.81, V.82, I.84 Chain B: R.8, L.23, D.25, G.27, A.28, D.29, I.47, G.48, G.49, I.50, P.81, V.82, I.84 24 PLIP interactions: 12 interactions with chain A, 12 interactions with chain B Hydrophobic interactions: A:L.23, A:A.28, A:F.53, A:P.81, A:V.82, B:L.23, B:A.28, B:I.47, B:P.81, B:V.82 Hydrogen bonds: A:D.25, A:G.27, A:D.29, A:G.48, A:I.50, B:G.27, B:D.29, B:G.48, B:I.50 Water bridges: A:R.8, A:G.48, B:R.8, B:R.8, B:G.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Andersson, H.O. et al., Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors. Eur.J.Biochem. (2003)

Release Date

2002-06-26

Peptides

HIV-1 PROTEASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

HIV-1 PROTEASE

Related Entries With Identical Sequence